Cargando…
Circulating tumour DNA — looking beyond the blood
Over the past decade, various liquid biopsy techniques have emerged as viable alternatives to the analysis of traditional tissue biopsy samples. Such surrogate ‘biopsies’ offer numerous advantages, including the relative ease of obtaining serial samples and overcoming the issues of interpreting one...
Autores principales: | Tivey, Ann, Church, Matt, Rothwell, Dominic, Dive, Caroline, Cook, Natalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341152/ https://www.ncbi.nlm.nih.gov/pubmed/35915225 http://dx.doi.org/10.1038/s41571-022-00660-y |
Ejemplares similares
-
Circulating Tumour DNA in Melanoma—Clinic Ready?
por: Tivey, Ann, et al.
Publicado: (2022) -
Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample
por: Rothwell, Dominic G., et al.
Publicado: (2015) -
DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
por: Board, Ruth E, et al.
Publicado: (2008) -
Circulating Tumor Cells, Enumeration and Beyond
por: Hou, Jian-Mei, et al.
Publicado: (2010) -
Early Dissemination of Circulating Tumor Cells: Biological and Clinical Insights
por: Chemi, Francesca, et al.
Publicado: (2021)